SkinStylus Receives FDA Clearance for Treating Periorbital Wrinkles Across All Skin Types
SkinHealth Systems Inc. (NASDAQ: SKIN) announced that its microneedling device, SkinStylus, has received new U.S. Food and Drug Administration clearance to treat periorbital wrinkles in adults aged 22 years or older across all Fitzpatrick skin types. This expansion of FDA-cleared indications strengthens the product's clinical positioning within the medical aesthetics market.